Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DSTN pseudogene 2 (DSTNP2) is a transcribed, unprocessed pseudogene located on chromosome 12 (12p13.31) in humans[3][6][13]. While DSTNP2 shares sequence similarity with the functional destrin gene, which is important in actin filament dynamics, DSTNP2 itself does not encode a protein and has no established biological or therapeutic relevance[2][6][9]. It is officially classified as a pseudogene by major genome resources and gene nomenclature committees[13][2][12]. No evidence supports DSTNP2 functioning as a therapeutic target, biomarker, or disease gene. DSTNP2 should not be considered for drug targeting, clinical biomarker use, or disease association due to its pseudogene status and lack of functional protein product[2][6][9][13].
Not applicable (pseudogene, no known mechanism)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DSTN pseudogene 2 (DSTNP2).